Pfizer and Biontech have officially requested the administration of US food and medicines (FDA) to ratify the Dosage of the Covid-19 company amplifier vaccine for all US adults aged 18 years and over. Although the FDA has passed the booster pfizer shot, the authorization of emergency use (EUA) which gives it limiting the feasibility for certain people, including those who are at high risk of infection due to existing health conditions or the work environment.
Pfizer and Biontech submitted their request for the feasibility of the booster booster which was expanded on November 9. Permintaan baru ini mengikuti hasil dari uji coba Fase 3 Pfizer, yang memberikan booster shots dengan sekitar 10.000 orang dan membandingkan tingkat kemanjuran dosis yang lebih rendah dengan yang asli original with the original with the two dose vaccine schedule.
The findings, which were released last month but are still waiting for the peer review, revealed 95 percent protection against the development of COVID-19 symptomatic infections compared to individuals who received two doses of vaccine protocol. In addition, data shows the booster shot safe. Test Phase 3 Random and Controlled Registering participants over a period of time when the transmission of the SARS-COV-2 Delta Variant Variant.
Although some people aged 12 years and over in the United States have been able to get a third primary dose or booster shot for weeks, many people still do not meet the requirements under the current authorization of emergency use issued by the FDA. As a result, only adults aged 65 and older who have received the primary covid-19 vaccine schedule can get booster shots. In addition, Eua passed the booster for adults aged 18 to 64 years who are at high risk of severe infection or virus exposure.
Beyond that, the FDA has passed the Pfizer Booster shot for individuals who first received different Covid-19 vaccines, such as modern products. This helps protect the most vulnerable in society, such as adults who suffer from cancer or other diseases that endanger their immune system, but make many people without the choice for reinforcement shots to winter.
Under the existing authorization, the primary covid-19 pfizer vaccine two doses are given with two shots scheduled for three weeks separate. This vaccine is now permitted for children as young as five years, a decision recommended by the independent expert panel. FDA follows recommendations with authorization about a week later, with the CDC also giving the approval of the days afterwards.
Covid-19 booster shots have been proven to be controversial in the US and its surroundings. Pfizer previously requested the approval of the covid-19 driver from the FDA for people aged 16 and older, but the FDA cut requests to the current and far more limited feasibility guidelines.The booster booster has grown when more and more people have the main vaccine shot last month and there are some concerns about the decline in immunity. This potential problem will collide with winter, which is expected to bring various risk factors, including a decrease in the use of masks compared to last year and increasing social meetings due to holidays.
In addition, the world health organization was very criticizing the proclamation of the early reinforcement of the Biden government in September, accusing rich countries failed to contribute the dose of vaccines promised to low -income countries. As a result of this distribution controversy, Director General of Whebreyusus asked richer countries to delay the availability of booster shots that extended until the end of 2021 or more. In the hot comments at that time, Ghebreyesus said, “I will not be silent when companies and countries that control the supply of global vaccines think that the world’s poor people must be satisfied with food scraps.”